• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响 REM 咪唑安定给药患者拔管时间延长的因素。

Factors affecting prolonged time to extubation in patients given remimazolam.

机构信息

Department of Anesthesiology, NHO Kure Medical Center, Kure, Hiroshima, Japan.

出版信息

PLoS One. 2022 May 18;17(5):e0268568. doi: 10.1371/journal.pone.0268568. eCollection 2022.

DOI:10.1371/journal.pone.0268568
PMID:35584094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9116664/
Abstract

PURPOSE

To analyze the cause of prolonged recovery from general anesthesia with remimazolam.

METHODS

We studied 65 patients under general anesthesia with remimazolam. According to time to extubation, patients were divided into short period (SP) (n = 34, < 15 min) and long period (LP) (n = 31, ≥ 15 min) groups. Variables affecting time to extubation such as age, sex, height, body weight, body mass index (BMI), plasma albumin concentration, ASA class, duration of surgery, and total duration of general anesthesia, and total dose of remimazolam were compared between SP and LP groups. At the end of remimazolam infusion and upon extubation, predictive remimazolam concentrations were calculated using pharmacokinetic/pharmacodynamic three compartment modeling.

RESULTS

LP group showed significantly higher BMI, older age, and lower plasma albumin concentration compared with those of SP group. Logistic regression analysis showed that the probability of time to extubation of ≥ 15 min was higher in patients with BMI greater than 22.0 kg/m2 (AUC 0.668, 95% CI 0.533‒0.803), ages older than 79.0 years (AUC 0.662, 95% CI 0.526‒0.798), and plasma albumin concentrations lower than 3.60 g/dl (AUC 0.720, 95% CI 0.593‒0.847). LP group showed significantly lower predicted remimazolam concentration than SP group upon extubation despite no difference in concentration between both groups at the end of infusion. Pharmacological analysis estimates that LP group is more sensitive to remimazolam than SP group through amplified responses.

CONCLUSIONS

Lower remimazolam doses should be considered for the overweight patients, elderly, and those with lower plasma albumin concentration.

摘要

目的

分析以咪达唑仑进行全身麻醉后恢复期延长的原因。

方法

我们研究了 65 例全身麻醉下使用咪达唑仑的患者。根据拔管时间,患者分为短时间组(SP)(n = 34,< 15 分钟)和长时间组(LP)(n = 31,≥ 15 分钟)。比较 SP 组和 LP 组的影响拔管时间的变量,如年龄、性别、身高、体重、体重指数(BMI)、血浆白蛋白浓度、ASA 分级、手术时间、全身麻醉总时间和咪达唑仑总剂量。在咪达唑仑输注结束和拔管时,使用药代动力学/药效学三房室模型计算预测的咪达唑仑浓度。

结果

LP 组的 BMI 较高、年龄较大、血浆白蛋白浓度较低,与 SP 组相比差异有统计学意义。Logistic 回归分析显示,BMI 大于 22.0 kg/m2(AUC 0.668,95%CI 0.533-0.803)、年龄大于 79.0 岁(AUC 0.662,95%CI 0.526-0.798)和血浆白蛋白浓度低于 3.60 g/dl(AUC 0.720,95%CI 0.593-0.847)的患者拔管时间大于 15 分钟的概率更高。尽管两组在输注结束时的浓度无差异,但 LP 组在拔管时的预测咪达唑仑浓度明显低于 SP 组。药物分析估计 LP 组对咪达唑仑的敏感性高于 SP 组,通过放大反应。

结论

超重患者、老年人和血浆白蛋白浓度较低的患者应考虑使用较低剂量的咪达唑仑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce40/9116664/cad75accd292/pone.0268568.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce40/9116664/3ceb6457f211/pone.0268568.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce40/9116664/2f1cbf8fdf06/pone.0268568.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce40/9116664/cad75accd292/pone.0268568.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce40/9116664/3ceb6457f211/pone.0268568.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce40/9116664/2f1cbf8fdf06/pone.0268568.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce40/9116664/cad75accd292/pone.0268568.g003.jpg

相似文献

1
Factors affecting prolonged time to extubation in patients given remimazolam.影响 REM 咪唑安定给药患者拔管时间延长的因素。
PLoS One. 2022 May 18;17(5):e0268568. doi: 10.1371/journal.pone.0268568. eCollection 2022.
2
Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.用于全身麻醉诱导和维持的瑞米唑仑的事件发生时间建模。
J Clin Pharmacol. 2020 Apr;60(4):505-514. doi: 10.1002/jcph.1552. Epub 2020 Jan 27.
3
Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.瑞马唑仑在健康受试者和手术受试者全身麻醉诱导和维持中的群体药代动力学/药效学建模。
J Clin Anesth. 2020 Nov;66:109899. doi: 10.1016/j.jclinane.2020.109899. Epub 2020 Jun 22.
4
A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice.瑞马唑仑用于全身麻醉的群体药代动力学模型及临床剂量的考虑。
J Anesth. 2022 Aug;36(4):493-505. doi: 10.1007/s00540-022-03079-y. Epub 2022 Jun 16.
5
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.一项安慰剂和咪达唑仑对照的 I 期单递增剂量研究,评估雷米唑仑(CNS 7056)的安全性、药代动力学和药效学:第二部分。群体药代动力学和药效学建模与模拟。
Anesth Analg. 2012 Aug;115(2):284-96. doi: 10.1213/ANE.0b013e318241f68a. Epub 2012 Jan 16.
6
Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.雷米佐胺(CNS 7056)在健康男性志愿者中连续输注后的药代动力学和药效学:第一部分。药代动力学和临床药效学。
Anesthesiology. 2020 Apr;132(4):636-651. doi: 10.1097/ALN.0000000000003103.
7
Recall of extubation after remimazolam anesthesia with flumazenil antagonism during emergence: a retrospective clinical study.氟马西尼拮抗瑞马唑仑麻醉苏醒期拔管后召回的回顾性临床研究。
J Anesth. 2022 Dec;36(6):688-692. doi: 10.1007/s00540-022-03093-0. Epub 2022 Sep 8.
8
Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial.瑞马唑仑与丙泊酚用于全身麻醉的有效性和安全性:一项多中心、单盲、随机、平行分组、Ⅱb/Ⅲ期临床试验。
J Anesth. 2020 Aug;34(4):543-553. doi: 10.1007/s00540-020-02788-6. Epub 2020 May 16.
9
Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial.瑞马唑仑用于高危手术患者全麻诱导和维持的安全性和有效性(ASA 分级 III):一项多中心、随机、双盲、平行组比较试验的结果。
J Anesth. 2020 Aug;34(4):491-501. doi: 10.1007/s00540-020-02776-w. Epub 2020 Apr 17.
10
The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial.雷米唑仑甲磺酸盐用于老年患者麻醉诱导的中效剂量和双频谱指数:一项上下序贯分配试验。
Clin Interv Aging. 2022 May 20;17:837-843. doi: 10.2147/CIA.S364222. eCollection 2022.

引用本文的文献

1
Clinical Pharmacokinetics and Pharmacodynamics of Remimazolam.瑞马唑仑的临床药代动力学与药效学
Clin Pharmacokinet. 2025 Jul 21. doi: 10.1007/s40262-025-01548-7.
2
Remimazolam as a Novel Anesthetic in Pediatric Procedural Sedation and Anesthesia: A Narrative Review.瑞米唑仑作为小儿程序性镇静和麻醉中的新型麻醉剂:一项叙述性综述。
Cureus. 2025 Jun 19;17(6):e86354. doi: 10.7759/cureus.86354. eCollection 2025 Jun.
3
Prophylactic endotracheal intubation prior to emergency endoscopy for acute esophagogastric variceal hemorrhage: a retrospective single center study.

本文引用的文献

1
Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent.瑞马唑仑:一种新型镇静/麻醉剂的非临床和临床概况
Front Pharmacol. 2021 Jul 20;12:690875. doi: 10.3389/fphar.2021.690875. eCollection 2021.
2
Re-sleeping after reversal of remimazolam by flumazenil.氟马西尼逆转瑞米唑仑作用后再次入睡。
J Anesth. 2021 Apr;35(2):322. doi: 10.1007/s00540-021-02915-x. Epub 2021 Mar 9.
3
Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.
急性食管胃静脉曲张出血急诊内镜检查前预防性气管插管:一项回顾性单中心研究
BMC Gastroenterol. 2025 Jul 1;25(1):470. doi: 10.1186/s12876-025-04066-9.
4
Comparison of the recovery profiles of propofol, dexmedetomidine, and remimazolam for intraoperative sedation in patients undergoing upper limb surgery under brachial plexus blockade: a randomized controlled trial.臂丛神经阻滞下上肢手术患者术中使用丙泊酚、右美托咪定和瑞马唑仑镇静的恢复情况比较:一项随机对照试验
Can J Anaesth. 2025 Jun 13. doi: 10.1007/s12630-025-02987-3.
5
Incidence of prolonged time to tracheal extubation and its associated factors among adult patients undergoing elective surgery at Jimma Medical Center, Jimma, Oromia, Ethiopia, 2024.2024年埃塞俄比亚奥罗米亚州吉马市吉马医疗中心择期手术成年患者气管拔管时间延长的发生率及其相关因素
Perioper Med (Lond). 2025 Apr 24;14(1):48. doi: 10.1186/s13741-025-00520-0.
6
Genetic Variation and Sex-Based Differences: Current Considerations for Anesthetic Management.基因变异与基于性别的差异:麻醉管理的当前考量
Curr Issues Mol Biol. 2025 Mar 18;47(3):202. doi: 10.3390/cimb47030202.
7
Effect-Site Concentration of Remimazolam by Age Groups During Target-Controlled Infusion for Total Intravenous Anesthesia: A Retrospective Comparative Study.年龄对靶控输注瑞马唑仑用于全静脉麻醉时效应室浓度的影响:一项回顾性比较研究。
Drug Des Devel Ther. 2024 Nov 12;18:5149-5159. doi: 10.2147/DDDT.S480734. eCollection 2024.
8
Age-Related Response to Remimazolam among Older Patients Undergoing Orthopedic Surgery: A Single-Center Prospective Observational Study.老年骨科手术患者中瑞马唑仑的年龄相关反应:一项单中心前瞻性观察研究。
Medicina (Kaunas). 2024 Oct 2;60(10):1616. doi: 10.3390/medicina60101616.
9
Remimazolam and Its Place in the Current Landscape of Procedural Sedation and General Anesthesia.瑞马唑仑及其在当前程序性镇静和全身麻醉领域中的地位。
J Clin Med. 2024 Jul 25;13(15):4362. doi: 10.3390/jcm13154362.
10
Remimazolam-Induced Anaphylaxis and Cardiovascular Collapse: A Narrative Systematic Review of Eleven Cases.瑞马唑仑诱导的过敏反应和心血管崩溃:十一例病例的叙述性系统评价。
Medicina (Kaunas). 2024 Jun 12;60(6):971. doi: 10.3390/medicina60060971.
瑞马唑仑在健康受试者和手术受试者全身麻醉诱导和维持中的群体药代动力学/药效学建模。
J Clin Anesth. 2020 Nov;66:109899. doi: 10.1016/j.jclinane.2020.109899. Epub 2020 Jun 22.
4
Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.用于全身麻醉诱导和维持的瑞米唑仑的事件发生时间建模。
J Clin Pharmacol. 2020 Apr;60(4):505-514. doi: 10.1002/jcph.1552. Epub 2020 Jan 27.
5
Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.雷米佐胺(CNS 7056)在健康男性志愿者中连续输注后的药代动力学和药效学:第一部分。药代动力学和临床药效学。
Anesthesiology. 2020 Apr;132(4):636-651. doi: 10.1097/ALN.0000000000003103.
6
Sources of Variation in Anesthetic Drug Costs.麻醉药物成本的变异来源。
Anesth Analg. 2018 Apr;126(4):1241-1248. doi: 10.1213/ANE.0000000000002732.
7
Investigation of the freely available easy-to-use software 'EZR' for medical statistics.医学统计学中免费易用软件 EZR 的调查研究。
Bone Marrow Transplant. 2013 Mar;48(3):452-8. doi: 10.1038/bmt.2012.244. Epub 2012 Dec 3.
8
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.一项安慰剂和咪达唑仑对照的 I 期单递增剂量研究,评估 remimazolam(CNS 7056)的安全性、药代动力学和药效学:第 I 部分。安全性、疗效和基本药代动力学。
Anesth Analg. 2012 Aug;115(2):274-83. doi: 10.1213/ANE.0b013e31823f0c28. Epub 2011 Dec 20.
9
Meta-analysis of average and variability of time to extubation comparing isoflurane with desflurane or isoflurane with sevoflurane.比较异氟烷与地氟烷或异氟烷与七氟烷时,拔管时间的平均和变异性的荟萃分析。
Anesth Analg. 2010 May 1;110(5):1433-9. doi: 10.1213/ANE.0b013e3181d58052.
10
Statistical modeling of average and variability of time to extubation for meta-analysis comparing desflurane to sevoflurane.用于荟萃分析的平均和变异性时间到拔管比较去氟醚与七氟醚的统计建模。
Anesth Analg. 2010 Feb 1;110(2):570-80. doi: 10.1213/ANE.0b013e3181b5dcb7. Epub 2009 Oct 9.